Xing Lianping, Xiu Yan, Boyce Brendan F
Lianping Xing, Yan Xiu, Brendan F Boyce, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, United States.
World J Orthop. 2012 Dec 18;3(12):212-22. doi: 10.5312/wjo.v3.i12.212.
Osteoclasts are the bone resorbing cells essential for bone remodeling. Osteoclasts are formed from hematopoietic progenitors in the monocyte/macrophage lineage. Osteoclastogenesis is composed of several steps including progenitor survival, differentiation to mono-nuclear pre-osteoclasts, fusion to multi-nuclear mature osteoclasts, and activation to bone resorbing osteoclasts. The regulation of osteoclastogenesis has been extensively studied, in which the receptor activator of NF-κB ligand (RANKL)-mediated signaling pathway and downstream transcription factors play essential roles. However, less is known about osteoclast fusion, which is a property of mature osteoclasts and is required for osteoclasts to resorb bone. Several proteins that affect cell fusion have been identified. Among them, dendritic cell-specific transmembrane protein (DC-STAMP) is directly associated to osteoclast fusion in vivo. Cytokines and factors influence osteoclast fusion through regulation of DC-STAMP. Here we review the recently discovered new factors that regulate osteoclast fusion with specific focus on DC-STAMP. A better understanding of the mechanistic basis of osteoclast fusion will lead to the development of a new therapeutic strategy for bone disorders due to elevated osteoclast bone resorption. Cell-cell fusion is essential for a variety of cellular biological processes. In mammals, there is a limited number of cell types that fuse to form multinucleated cells, such as the fusion of myoblasts for the formation of skeletal muscle and the fusion of cells of the monocyte/macrophage lineage for the formation of multinucleated osteoclasts and giant cells. In most cases, cell-cell fusion is beneficial for cells by enhancing function. Myoblast fusion increases myofiber size and diameter and thereby increases contractile strength. Multinucleated osteoclasts have far more bone resorbing activity than their mono-nuclear counterparts. Multinucleated giant cells are much more efficient in the removal of implanted materials and bacteria due to chronic infection than macrophages. Therefore, they are also called foreign-body giant cells. Cell fusion is a complicated process involving cell migration, chemotaxis, cell-cell recognition and attachment, as well as changes into a fusion-competent status. All of these steps are regulated by multiple factors. In this review, we will discuss osteoclast fusion and regulation.
破骨细胞是骨重塑所必需的骨吸收细胞。破骨细胞由单核细胞/巨噬细胞谱系中的造血祖细胞形成。破骨细胞生成包括几个步骤,包括祖细胞存活、分化为单核前破骨细胞、融合为多核成熟破骨细胞以及激活为骨吸收破骨细胞。破骨细胞生成的调控已得到广泛研究,其中核因子κB受体活化因子配体(RANKL)介导的信号通路和下游转录因子起着至关重要的作用。然而,人们对破骨细胞融合的了解较少,破骨细胞融合是成熟破骨细胞的一种特性,是破骨细胞吸收骨所必需的。已经鉴定出几种影响细胞融合的蛋白质。其中,树突状细胞特异性跨膜蛋白(DC-STAMP)在体内与破骨细胞融合直接相关。细胞因子和因子通过调节DC-STAMP影响破骨细胞融合。在此,我们综述了最近发现的调节破骨细胞融合的新因子,特别关注DC-STAMP。更好地理解破骨细胞融合的机制基础将导致开发一种针对因破骨细胞骨吸收增加而导致的骨疾病的新治疗策略。细胞-细胞融合对于多种细胞生物学过程至关重要。在哺乳动物中,融合形成多核细胞的细胞类型数量有限,例如成肌细胞融合形成骨骼肌,单核细胞/巨噬细胞谱系的细胞融合形成多核破骨细胞和巨细胞。在大多数情况下,细胞-细胞融合通过增强功能对细胞有益。成肌细胞融合增加肌纤维大小和直径,从而增加收缩强度。多核破骨细胞比单核破骨细胞具有更强的骨吸收活性。由于慢性感染,多核巨细胞在清除植入材料和细菌方面比巨噬细胞更有效。因此,它们也被称为异物巨细胞。细胞融合是一个复杂的过程,涉及细胞迁移、趋化性、细胞-细胞识别和附着,以及转变为融合能力状态。所有这些步骤都受多种因素调节。在本综述中,我们将讨论破骨细胞融合及其调控。